1. Home
  2. ARQT vs VTMX Comparison

ARQT vs VTMX Comparison

Compare ARQT & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$26.21

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

HOLD

Current Price

$33.85

Market Cap

3.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
VTMX
Founded
2016
1998
Country
United States
Mexico
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.2B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
ARQT
VTMX
Price
$26.21
$33.85
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$34.00
$40.00
AVG Volume (30 Days)
1.5M
80.2K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
2.01%
EPS Growth
88.79
N/A
EPS
N/A
N/A
Revenue
$376,072,000.00
N/A
Revenue This Year
$34.85
$12.22
Revenue Next Year
$29.39
$11.52
P/E Ratio
N/A
$47.91
Revenue Growth
91.34
N/A
52 Week Low
$13.06
$24.99
52 Week High
$31.77
$37.41

Technical Indicators

Market Signals
Indicator
ARQT
VTMX
Relative Strength Index (RSI) 71.86 43.42
Support Level $24.81 $33.84
Resistance Level $27.26 $36.96
Average True Range (ATR) 1.09 0.88
MACD 0.56 0.00
Stochastic Oscillator 87.88 53.70

Price Performance

Historical Comparison
ARQT
VTMX

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: